IRIS
CICONTE, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.869
EU - Europa 1.867
NA - Nord America 1.276
SA - Sud America 480
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.549
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.194
RU - Federazione Russa 1.113
SG - Singapore 709
CN - Cina 515
BR - Brasile 393
HK - Hong Kong 226
IT - Italia 210
VN - Vietnam 190
SE - Svezia 165
DE - Germania 79
FR - Francia 79
GB - Regno Unito 52
FI - Finlandia 46
BD - Bangladesh 40
IN - India 38
CA - Canada 37
AR - Argentina 30
MX - Messico 26
IE - Irlanda 24
JP - Giappone 21
ID - Indonesia 20
AT - Austria 19
ZA - Sudafrica 19
PL - Polonia 18
NL - Olanda 17
TR - Turchia 15
EC - Ecuador 14
IQ - Iraq 13
PK - Pakistan 12
LT - Lituania 11
CO - Colombia 10
MA - Marocco 9
PY - Paraguay 9
ES - Italia 8
KE - Kenya 8
OM - Oman 8
SA - Arabia Saudita 8
BE - Belgio 7
CL - Cile 7
MD - Moldavia 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
PH - Filippine 6
EG - Egitto 5
NP - Nepal 5
DO - Repubblica Dominicana 4
IR - Iran 4
JO - Giordania 4
MY - Malesia 4
TN - Tunisia 4
UY - Uruguay 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
BH - Bahrain 3
BO - Bolivia 3
EU - Europa 3
HN - Honduras 3
LB - Libano 3
PE - Perù 3
PT - Portogallo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
UA - Ucraina 3
CR - Costa Rica 2
DZ - Algeria 2
KZ - Kazakistan 2
QA - Qatar 2
AL - Albania 1
AM - Armenia 1
AW - Aruba 1
BN - Brunei Darussalam 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
IM - Isola di Man 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
ME - Montenegro 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
RO - Romania 1
SV - El Salvador 1
TL - Timor Orientale 1
TZ - Tanzania 1
ZM - Zambia 1
Totale 5.549
Salva come PNG Salva come JPEG
Città #
Singapore 301
Moscow 230
Hong Kong 225
Ashburn 199
Dallas 179
San Jose 176
Shanghai 97
Hefei 83
Ho Chi Minh City 71
Lauterbourg 70
Beijing 67
Milan 66
Lawrence 63
Princeton 62
New York 52
Hanoi 34
São Paulo 34
Helsinki 32
Los Angeles 27
Orem 27
Dublin 23
Santa Clara 23
London 18
Nuremberg 17
Tokyo 17
Chennai 16
Rome 16
Warsaw 16
Denver 14
Frankfurt am Main 14
Montreal 14
Boardman 13
Phoenix 12
Vienna 12
Cesano Boscone 11
Haiphong 11
Toronto 11
Amsterdam 10
Rio de Janeiro 10
Seattle 10
Biên Hòa 9
Brasília 9
Johannesburg 9
Brooklyn 8
Las Vegas 8
Mexico City 8
Munich 8
San Francisco 8
Stockholm 8
Ankara 7
Atlanta 7
Brescia 7
Chicago 7
Falkenstein 7
Manchester 7
Nairobi 7
Turku 7
Belo Horizonte 6
Curitiba 6
Guangzhou 6
Lappeenranta 6
Muscat 6
Naples 6
Recife 6
Salvador 6
Asunción 5
Da Nang 5
Ferrara 5
Goiânia 5
Guarulhos 5
Hangzhou 5
Jakarta 5
Kassel 5
Poplar 5
Quito 5
Santiago 5
Thái Nguyên 5
Viareggio 5
Wolfhagen 5
Amman 4
Aracaju 4
Brussels 4
Casablanca 4
City of London 4
Ha Long 4
Houston 4
Istanbul 4
Itaquaquecetuba 4
Lahore 4
Mumbai 4
New Delhi 4
Osasco 4
Paris 4
Porto Alegre 4
Pune 4
Sorocaba 4
São José 4
Tashkent 4
The Dalles 4
Vilnius 4
Totale 2.716
Salva come PNG Salva come JPEG
Nome #
Brugada Syndrome: New Insights From Cardiac Magnetic Resonance and Electroanatomical Imaging 134
Challenges in Brugada Syndrome Stratification: Investigating SCN5A Mutation Localization and Clinical Phenotypes 126
Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights 120
Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies 118
Brugada syndrome genetics is associated with phenotype severity 118
Human Sarcopenic Myoblasts Can Be Rescued by Pharmacological Reactivation of HIF-1α 114
Arrhythmogenic substrate elimination for safe testosterone therapy in symptomatic Brugada syndrome patients 110
Ebstein's anomaly in children and adults: Multidisciplinary insights into imaging and therapy 109
Analysis of the intramolecular 1,7-lactone of N-acetylneuraminic acid using HPLC–MS: relationship between detection and stability 106
Clinical characteristics and electrophysiologic properties of SCN5A variants in fever-induced Brugada syndrome 106
Atrial fibrillation in autoimmune rheumatic diseases: From pathogenesis to treatment 103
Brugada Syndrome: Warning of a Systemic Condition? 100
Atrial fibrillation detection using a novel three-vector cardiac implantable monitor: The atrial fibrillation detect study 96
GM1 Ganglioside Promotes Osteogenic Differentiation of Human Tendon Stem Cells 95
HIF-1α Directly Controls WNT7A Expression During Myogenesis 94
Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants 93
Second-generation laser balloon ablation for the treatment of atrial fibrillation assessed by continuous rhythm monitoring: the LIGHT-AF study 92
Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation 91
Clinical considerations for a family with dilated cardiomyopathy, sudden cardiac death, and a novel ttn frameshift mutation 90
Neu3 Sialidase Activates the RISK Cardioprotective Signaling Pathway during Ischemia and Reperfusion Injury (IRI) 84
Atrial fibrillation recurrences during the blanking period after catheter ablation with the laser balloon technique 82
Brugada Syndrome: Oligogenic or Mendelian Disease? 81
Left Atrial Dynamics During Exercise in Mitral Regurgitation of Primary and Secondary Origin: Pathophysiological Insights by Exercise Echocardiography Combined With Gas Exchange Analysis 80
Genotype/Phenotype Relationship in a Consanguineal Family With Brugada Syndrome Harboring the R1632C Missense Variant in the SCN5A Gene 78
Novel scn5a p.V1429m variant segregation in a family with brugada syndrome 77
Intermittent alternance of Brugada ECG patterns: Insights from a unique electrophysiological phenomenon 77
Clinical outcome of electrophysiologically guided ablation for nonparoxysmal atrial fibrillation using a novel real-time 3-dimensional mapping technique results from a prospective randomized trial 75
NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications 73
Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death 71
Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen 70
Commentary: Next generation sequencing and linkage analysis for the molecular diagnosis of a novel overlapping syndrome characterized by hypertrophic cardiomyopathy and typical electrical instability of brugada syndrome 69
Atrial fibrillation progression and management: a 5-year prospective follow-up study 69
Deep learning unmasks the ECG signature of Brugada syndrome 68
Asymptomatic ventricular preexcitation: a long-term prospective follow-up study of 293 adult patients 68
Electrical Substrate Elimination in 135 Consecutive Patients with Brugada Syndrome 68
Regenerating the human heart : direct reprogramming strategies and their current limitations 67
New electromechanical substrate abnormalities in high-risk patients with Brugada syndrome 66
Non-invasive assessment of the arrhythmogenic substrate in Brugada syndrome using signal-averaged electrocardiogram: Clinical implications from a prospective clinical trial 65
Novel scn5a p.Val1667asp missense variant segregation and characterization in a family with severe brugada syndrome and multiple sudden deaths 65
Assessing the Malignant Ventricular Arrhythmic Substrate in Patients With Brugada Syndrome 64
Electrocardiographic temporo-spatial assessment of depolarization and repolarization changes after epicardial arrhythmogenic substrate ablation in Brugada syndrome 63
Long-term outcome of remote catheter ablation using a magnetic irrigated-tip catheter 63
Feasibility of Remote Monitoring Using a Novel Long-Dipole Insertable Cardiac Monitor 62
Congenital coronary artery anomalies: Differential diagnosis of ventricular arrhythmias in young athletes 61
SCN5A nonsense mutation and NF1 frameshift mutation in a family with brugada syndrome and neurofibromatosis 61
Epicardial arrhythmogenic substrate in long QT syndrome 60
Genotype-Phenotype Correlation in a Family with Brugada Syndrome Harboring the Novel p.Gln371* Nonsense Variant in the SCN5A Gene 59
General Anesthesia Attenuates Brugada Syndrome Phenotype Expression: Clinical Implications From a Prospective Clinical Trial 59
The natural history of asymptomatic ventricular pre-excitation a long-term prospective follow-up study of 184 asymptomatic children 58
Novel SCN5A Frameshift Mutation in Brugada Syndrome Associated With Complex Arrhythmic Phenotype 55
Multipoint pacing improves peripheral hemodynamic response: Noninvasive assessment using radial artery tonometry 55
AF ablation in the elderly population. The Milan experience 54
Atrial Fibrillation Progression in Patients With and Without Lone Atrial Fibrillation: A Five-Year Prospective Follow-Up Study 54
Novel scn5a p.W697x nonsense mutation segregation in a family with brugada syndrome 54
Out-of-hospital cardiac arrest due to idiopathic ventricular fibrillation in patients with normal electrocardiograms: Results from a multicentre long-term registry 54
Safety and efficacy of circumferential pulmonary vein ablation in octogenarians with atrial fibrillation 53
Remote irrigated-tip ablation. The first human experience in patients with WPW syndrome 53
New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: Prevalence and clinical significance 53
Thrombosis on a left atrial appendage occluder device: The double-edged sword of stroke prevention strategies in atrial fibrillation 53
Unusual response to ajmaline test in Brugada syndrome patient leads to extracorporeal membrane oxygenator support 52
Multipoint left ventricular pacing improves response to cardiac resynchronization therapy with and without pressure-volume loop optimization: comparison of the long-term efficacy of two different programming strategies 51
Safety and feasibility of a novel multielectrode array catheter in mapping atrial and ventricular arrhythmias with high density: results from the multicenter OPTIMUM study 50
Early rhythm control strategy by catheter ablation in patients with paroxysmal atrial fibrillation: the 4-year results of a randomized follow-up study comparing catheter ablation and antiarrhythmic drug therapy: The APAF 2 Study 50
Long-term outcome benefits of catheter ablation versus antiarrhythmic drug therapy. A prospective, randomized two year extension study, the APAF 2 Study 49
New-Onset Atrial Fibrillation as the First Clinical Manifestation of Latent Brugada Syndrome: Incidence and Clinical Significance 48
The natural history of ventricular preexcitation in 293 asymptomatic adult subjects 48
Role of sialidase Neu3 and ganglioside GM3 in cardiac fibroblasts activation 48
First human experience with an irrigated tip catheter for remote circumferential pulmonary vein ablation. Preliminary results in 33 patients with atrial fibrillation 47
The role of implantable cardiac monitors in atrial fibrillation management 47
Novel CineECG Derived from Standard 12-Lead ECG Enables Right Ventricle Outflow Tract Localization of Electrical Substrate in Patients with Brugada Syndrome 47
Catheter ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation. A Long-term Randomized Follow-up Study. The APAF2 Study 46
Circumferential Pulmonary Vein Ablation Using a Remote Irrigated Tip Magnetic Catheter: Long-Term Outcome 46
Reversine: A Synthetic Purine with a Dual Activity as a Cell Dedifferentiating Agent and a Selective Anticancer Drug 46
Right ventricular electromechanical abnormalities in Brugada syndrome: is this a cardiomyopathy? 44
Lone atrial fibrillation as the first clinical manifestation of a latent Brugada syndrome 44
Non-paroxysmal atrial fibrillation mapping: characterization of the electrophysiological substrate using a novel integrated mapping technique 43
Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value 42
Catheter ablation versus antiarrhythmic drug therapy. A prospective, randomized, long-term study. The APAF 2 42
Safety, Efficacy and Follow-Up of Circumferential Pulmonary Vein Ablation in Octogenarians 40
Predictors of sudden death in patients with Wolff-Parkinson-White Syndrome. A prospective follow-up study of 201 symptomatic WPW patients presenting with malignant arrhythmias 40
The First Human Experience With An Irrigated-tip Magnetic Catheter In Patients Undergoing Remote Ablation Of Atrial Fibrillation 38
Epicardial ablation in genetic cardiomyopathies: A new frontier 37
Ablation of the epicardial substrate in patients with long-QT syndrome at risk of sudden death 9
High-risk Brugada syndrome: Factors associated with arrhythmia recurrence and benefits of epicardial ablation in addition to implantable cardioverter defibrillator implantation 8
Multielectrode Radiofrequency Balloon Catheter for Paroxysmal Atrial Fibrillation: Results From the Global, Multicenter, STELLAR Study 4
Anatomical-guided third-generation laser balloon ablation for the treatment of paroxysmal atrial fibrillation assessed by continuous rhythm monitoring: results from a multicentre prospective study 4
Ablation of ventricular arrhythmias in cardiogenetic diseases 4
Atrial fibrillation laser balloon ablation: Multicenter international study 4
Continuous Rhythm Monitoring With Implanted Loop Recorders in Children and Adolescents With Brugada Syndrome 3
The “arrhythmic” presentation of peripartum cardiomyopathy: case series and critical review of the literature 3
The Electro-Anatomical Pathway for Normal and Abnormal ECGs in COVID Patients 2
3D Electroanatomical Mapping of Multiple Substrates in Patients with Atrial Fibrillation 2
The HIF-1α Pathway Regulates Satellite Cell Fate During Aging Through Histone Lactylation 2
Single 3-Minute versus Double 4-Minute Freeze Strategy for Second-Generation Cryoballoon Ablation: A Single-Center Experience 2
Mode and Characteristics of Arrhythmia Initiation in Idiopathic Ventricular Fibrillation: A THESIS Substudy 2
REPLY: Early Repolarization A Risk Factor in Brugada Syndrome 2
Follow-up From Childhood to Adulthood of Individuals With Family History of Brugada Syndrome and Normal Electrocardiograms 1
Complications in the setting of percutaneous atrial fibrillation ablation using radiofrequency and cryoballoon techniques: A single-center study in a large cohort of patients 1
Long-term prognosis of drug-induced Brugada syndrome 1
The clinical impact of ajmaline challenge in elderly patients with suspected atrioventricular conduction disease 1
Totale 5.716
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.774
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.774
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202242 0 0 0 13 4 2 15 1 6 0 0 1
2022/2023360 160 68 19 7 2 41 22 13 21 5 2 0
2023/2024155 2 4 14 44 12 14 5 15 0 6 13 26
2024/20251.239 174 47 7 34 58 88 150 132 208 154 74 113
2025/20263.909 237 304 299 572 290 101 324 250 1.016 220 194 102
Totale 5.772